Formulation: Giving new life to naturally occurring un-patentable compounds
Speaker: Umar Syed, BSc. Pharm., MBA, Chief Scientific Officer, Cannasat Therapeutics
The remarkable chemical diversity encompassed by natural products continues to be of relevance to drug discovery. Although today's drug discovery engine operates at an accelerated pace compared with the era in which natural products were pre-eminent sources of drug leads, numerous approaches have been developed to capture their intrinsic value. Biopharmaceutical products for which physio-chemical, biological, and clinical factors should be considered before combining the right formulation approach and the right active principle. In addition to drug optimization and rescue efforts, chemical and material properties of their physical form need to be identified and optimized for an in vivo performance, reliable manufacture and the protection of their intellectual property.
Register now
11:30AM - 1:00PM
MaRS Centre
101 College St.
Toronto, ON
CR-3
Registration is free.
Bring your lunch.
The remarkable chemical diversity encompassed by natural products continues to be of relevance to drug discovery. Although today's drug discovery engine operates at an accelerated pace compared with the era in which natural products were pre-eminent sources of drug leads, numerous approaches have been developed to capture their intrinsic value. Biopharmaceutical products for which physio-chemical, biological, and clinical factors should be considered before combining the right formulation approach and the right active principle. In addition to drug optimization and rescue efforts, chemical and material properties of their physical form need to be identified and optimized for an in vivo performance, reliable manufacture and the protection of their intellectual property.
Register now
DATE | TIME | LOCATION
February 27, 200811:30AM - 1:00PM
MaRS Centre
101 College St.
Toronto, ON
CR-3
Registration is free.
Bring your lunch.
ABOUT THE SPEAKER
Umar Syed has nearly fifteen years of experience in the pharmaceutical and health care space. Umar has an MBA from the Richard Ivey School of Business at the University of Western Ontario, a B.Sc. (Pharmacy) from the University of Alberta, and over six years of clinical experience at The London Health Sciences Centre as a senior clinical pharmacist and advisor. Umar has also worked in top-tier strategy consulting to the pharmaceutical and health care industries in New York, Boston, and Toronto as well as in Biotech Equity Research at BMO/Nesbitt Burns (“BMO”) in Toronto.UPCOMING EVENTS
PAST EVENTS
- March 27, 2008
MaRS Drug Development Discussion Group - Structure-Guided Discovery Without Structures: Computer-aided design of GPCR ligands - February 27, 2008
MaRS Drug Development Discussion Group - Formulation: Giving new life to naturally occurring un-patentable compounds - January 25, 2008
Drug Development Discussion Group - Novel therapeutic targets for preventing bone loss in osteolytic disease - December 18, 2007
MaRS Drug Development Discussion Group - Outsourcing Preclinical Development - October 23, 2006
MaRS Drug Development Discussion Group - Chance and Necessity in Drug Discovery: The case history of calcimimetic drugs - August 31, 2006
Drug Development Discussion Group - Structure-based Lead Generation and Optimization - June 29, 2006
Drug Development Discussion Group - Exploratory IND - April 27, 2006
Drug Discussion Group - BioMarkers in Clinical Trials
